Home › Markets › Industrials › NAUT

Nautilus Biotechnology Inc. (NAUT)

NAUT trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$2.05
-5.53% on the day
Market cap
$260.9M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerNAUT on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2020
SEC CIK0001808805
SEC industry codeLaboratory Analytical Instruments
Incorporated inDELAWARE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-18
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-07-28
Latest current report8-K2026-09-11
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 325 recent filings. All filings on EDGAR.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
LABStandard BioTools Inc.$0.6589+0.17%$260.0M
EYPTEyePoint Inc.$3.07-7.53%$264.7M
QTRXQuanterix Corporation$3.15-0.32%$149.0M
SEERSeer Inc.$2.11-1.86%$116.8M
PACBPacific Biosciences of California Inc.$2.05-2.38%$637.2M
CTKBCytek Biosciences Inc.$5.35+0.75%$695.4M
RPIDRapid Micro Biosystems Inc.$0.8738-0.57%$43.8M
CIRCCircle8 Group Inc.$0.3611-19.38%$42.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier